Category Innovation/ R&D

Hope To Advance Industrial Design Treaty At WIPO Meets Reluctance From Developing Countries

World Intellectual Property Organization Director General Francis Gurry set the tone at the 18 September opening of a WIPO committee on industrial designs, calling on countries to keep the treaty-signing momentum built up last June with the adoption of the Beijing Treaty on Audiovisual Performances. However, developing countries have been reluctant to engage in an international treaty on industrial designs and this week delegates will have to agree on how to pursue discussions on the subject.

India: Balancing Public And Private Interests In The Intellectual Property Regime

NEW DELHI - In this month, there have been two court orders in India that underscore the complexities underlying the country’s intellectual property regime. Last Friday (14 September), the Chennai-based Intellectual Property Appellate Board (IPAB) which is responsible for hearing appeals on patent applications, rejected a petition by German pharma major Bayer AG, seeking a stay on an order of India’s Controller of Patents granting a compulsory licence (CL) to Indian generic drug maker Natco Pharma Limited, for a drug used to treat liver and kidney cancer.

IFPMA Report, Panel, Examine Rise Of Industry Global Health Partnerships

A new report commissioned by international pharmaceutical industry released yesterday offers findings and recommendations based on study of 200 global health partnerships aimed at low- and middle-income countries. The report was released at a panel discussion of a range of health experts who highlighted work to date and upcoming needs in the area of global health partnerships.

Novartis Challenge To India Patent Law Put Off To 11 September

The Supreme Court of India today did not get to an agenda item involving a challenge to India's patent law by Swiss pharmaceutical company Novartis, and it is now scheduled to come up on 11 September. The case is considered to have potential widespread impact on the production of lower priced generic medicines.

A Look At India’s Key Pharmaceutical Patent Case

This month, the Indian Supreme Court will hear final arguments in a challenge by the pharmaceutical company Novartis against the Indian Patent Office’s rejection of a patent for the leukemia drug, Glivec. The Court’s ruling will have profound implications for…

Innovation And The Law: Some Lessons From The Patent Wars

They’ve been at each other’s throats for three years, and there’s no end in sight. Over two dozen businesses involved with smartphones and tablet computers are suing one another for patent infringement in numerous lawsuits around the world. These patent wars have cost the companies billions of dollars, clogged the courts, and prevented consumers from buying some devices they want with features they prefer. Is this really the best way to promote innovation and competition?